Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Study of Massively Parallel Sequencing in Early Detection for Gynecologic Malignant Tumor

NCT02166515 is registered in ClinicalTrials.gov with Zhiqing, Liang as lead sponsor.

NCT NCT02166515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02166515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Study of Massively Parallel Sequencing in Early Detection for Gynecologic Malignant Tumor
Lead sponsor
Zhiqing, Liang
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2013
Completion date
October 31, 2017
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gynecologic malignant tumor